 | |
Displaying eltrombopag PowerPoint Presentations
THROMBOCYTOPENIA - University of Wisconsin–Madison PPT
Presentation Summary : ... Eltrombopag (Promacta) Treatment options for relapsed or refractory disease Accessory spleen British Journal of Haematology 2004; 125: 232–239 Background: ...
Source : http://www.medicine.wisc.edu/~williams/itp.ppt
Journal Club: The Randomized Control Trial PPT
Presentation Summary : JOURNAL CLUB: THE RANDOMIZED CONTROLLED TRIAL July 10th, 2008 Rakhi Naik, MD THE ARTICLE Eltrombopag for Thrombocytopenia in Patients with Cirrhosis Associated with ...
Source : http://www.hopkinsmedicine.org/gim/training/Osler_Journal_Club/Slides%202008-09/OJC_7-10-08.ppt
Presentation Summary : Ann Hematol. 2010 Kuhne. Ann Hematol. 2010 Eltrombopag Eltrombopag (Promacta) 2 Randomized, Double Blind, Placebo Control Trials 773B(phase III) ...
Source : http://hematology.wustl.edu/conferences/presentations/Sanfilippo_2011-03-18.ppt
Presentation Summary : Blood 2007;109:4607) Randomized, double-blind, placebo-controlled trial at 44 clinical sites Once-daily, oral eltrombopag (0, 30, 50, or 75 mg) ...
Source : http://hematology.wustl.edu/conferences/presentations/Tollefsen_2008-02-22.ppt
Presentation Summary : ... an orally small molecule). Romiplostim is disadvantaged by its peptidic nature while eltrombopag carries a black box warning of hepatotoxicity.
Source : http://leaddiscovery.decode.uk.com/admin/upload/files/UpdatesPlus-example.ppt
Evaluation of Thrombocytopenia - Department of Family and ... PPT
Presentation Summary : ... Eltrombopag c-MPL agnonists Observation Management of ITP in pregnancy Gestational Thrombocytopenia Platelet count >70K, occurs late in gestation, ...
Source : http://www.fpm.emory.edu/Family/didactics/powerpint/Evaluation%20of%20Thrombocytopenia%20v1.1.ppt
ITP and TTP - Welcome to the UNC Department of Medicine ... PPT
Presentation Summary : ... before splenectomy Mycophenolate mofetil Cyclophosphamide Adjunct agents Thrombopoietin Receptor Agonists Romiplostim Eltrombopag Drugs Commonly Implicated in ...
Source : https://medicine.med.unc.edu/education/internal-medicine-residency-program/files/ppt/8.10.09%20Ma%20Thrombocytopenia.ppt
Presentation Summary : Over-medication with drugs that treat thrombocytopenia, such as eltrombopag or romiplostim, may also result in thrombocytosis. Essential Thrombocytosis.
Source : http://www.williammclarkmd.com/CBC.pptx
Presentation Summary : ... Eltrombopag: (oral thrombopoietin receptor agonist) 80% achieved Plt number more than 50,000 in 15 days. Romiplostim (TPO receptor agonist) 1mcg/kg/sc once weekly.
Source : http://lab420.com/files/Thrombocytopenia_2_.ppt
Presentation Summary : Eltrombopag (AKR501, a non-peptide mimetic) Clinical trials – for management of chemotherapy-induced thrombocytopenia – are currently ongoing More to come ...
Source : http://www.globalhealing.org/resources/English/Evidence-Based_Transfusion_Indication_Georgia.ppt
Presentation Summary : ... eltrombopag Immunosuppressants anti-plt Ab production Azathioprine, cyclophosphamide Plt clearance Danazol, vincristine Plt clearance, ...
Source : http://moodle.up.edu.ps/moodledata/326/Hemorrage_in_oral_surgery.ppt
Captación recursos para la investigación PPT
Presentation Summary : A Phase I/II Study of Eltrombopag in Thrombocytopenic Subjects with Advanced Myelodysplastic Syndrome (MDS) or secondary Acute Myeloid Leukemia after MDS (sAML/MDS)
Source : http://www.hematologialafe.es/DOCUMENTOS_D/SESION%20GENERAL%20DE%20INVESTIGACION/SESION%20INVESTIGACION_MARZO%202011.PPT
